RefBan

Referral Banners

Yashi

Friday, February 28, 2014

Reuters Health Report

Click to View in Browser
02/28/2014
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
Oklahoma House passes new abortion restrictions bill
OKLAHOMA CITY (Reuters) - The Oklahoma House of Representatives overwhelmingly passed a bill on Thursday to apply new restrictions on abortions that lawmakers said are aimed at protecting women's health but opponents say are designed to shut down clinics.
U.S. proposes major update to food labels in bid to combat obesity
WASHINGTON (Reuters) - Packaged foods sold in the United States would display calorie counts more prominently and include the amount of added sugar under a proposal to significantly update nutritional labels for the first time in 20 years as health officials seek to reduce obesity and combat related diseases such as diabetes.
Bayer says Xarelto and Eylea drugs near peak sales in 5-6 yrs
LEVERKUSEN, Germany (Reuters) - German drugmaker Bayer expects Xarelto and Eylea, among its most promising drugs, to be near their peak sales potential in about 5 to 6 years, Chief Executive Marijn Dekkers told a news conference on Friday.
U.S. expands healthy food assistance to women, infants and children
WASHINGTON (Reuters) - Some 9 million poor women and young children who receive federal food assistance under the U.S. government's so-called WIC program will have greater access to fruits, vegetables and whole grains under an overhaul of the program unveiled on Friday.
Chronically ill facing high drugs costs under U.S. health law
WASHINGTON (Reuters) - President Barack Obama's ban on discriminatory health insurance practices against the sick has not stopped insurers from increasing up-front charges for the expensive drugs needed to control chronic illnesses from leukemia to multiple sclerosis.
Groups urge FDA to halt launch of Zohydro pain drug
WASHINGTON (Reuters) - A coalition of addiction experts, physicians and others is urging U.S. health officials to reverse course and block the launch of a powerful painkiller called Zohydro, expected to hit the market next month.
Spine surgery patients mostly unaware of costs, compensation
NEW YORK (Reuters Health) - Orthopedic surgery patients go in and out of the operating room "blind" to the cost of their procedures, researchers say, but the patients often assume doctors are making much more than they really do.
Indoor tanning tied to risky behaviors among teens
NEW YORK (Reuters Health) - U.S. teenagers who use indoor tanning devices are more likely to take part in other risky behaviors, according to a new government study.
Supplement users are seeking wellness: study
NEW YORK (Reuters Health) - People who use multivitamins and other nutritional supplements tend to lead healthier lives overall, so taking supplements can be seen as a positive sign, suggests a new review of past research.
Obese kids may face higher risk of bad elbow breaks
NEW YORK (Reuters Health) - Complicated elbow fractures could be added to a growing list of heightened health risks for obese children, according to a recent analysis.
Related Video
Northeast scrambles to salt roads despite dwindling supplies ahead of snow
Northern Lights over Norway
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
 Reuters Deals Today
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
Reuters Business Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments:

Yashi

Chitika